UroGen Pharma Ltd. (URGN)
Q3 2019 Earnings Conference Call
November 12, 2019, 08:30 AM ET
Company Participants
Catherine Bechtold - Senior Director of IR
Elizabeth Barrett - President and CEO
Mark Schoenberg - Chief Medical Officer
Peter Pfreundschuh - CFO
Stephen Mullennix - COO
Jeff Bova - SVP, Commercial
Conference Call Participants
Turner Kufe - JPMorgan
Ram Selvaraju - H. C. Wainwright
Boris Peaker - Cowen
Leland Gershell - Oppenheimer
Presentation
Operator
Good morning, ladies and gentlemen, thank you for standing by and welcome to UroGen Pharma's Third Quarter 2019 Financial Results and Business Update